Chris Batchelor is the CEO of Enviroinvest. He is an experienced leader and investment expert having worked in financial markets for over 25 years. This includes co-founding a stock market research business and running it for seven years until it was sold. He is qualified as a Chartered Financial Analyst and holds a Graduate Diploma of Applied Finance and Investment and Bachelor of Commerce Degree. He has been a regular contributor to Money since 2012. Connect with Chris on LinkedIn.
Aussie retail group prepares for Amazon invasion
A retail group spanning clothes to car accessories is working to improve its own online business ahead of the launch of the Australian arm of Amazon.
Trump immigration ban good news for Navitas
Our private education sector relies heavily on international students for profitability. Trump's immigration ban is seemingly good news for Navitas (ASX:NVT).
Adventure retailer Kathmandu reaches for new peaks
Kathmandu's reputation for heavy discounts got the company into a bit of trouble in 2015, but Skaffold's Chris Batchelor predicts new peaks ahead for the adventure retailer.
Niche firm bucks downward trend for travel agencies
The travel industry has undergone major disruption over the past 10 years. One firm that has found a niche is Corporate Travel Management (CTD).
Educational institution our Hot Stock of the week
This week's Hot Stock is courtesy of Chris Batchelor from Skaffold.
Strong outlook ahead for this bedding retailer
This week's Hot Stock, courtesy of Chris Batchelor from Skaffold, is retailer Adairs. The manchester and bedding company looks good for the year ahead.
Why Data#3 is a tech company to watch
Skaffold's hot stock of the week is a tech company with ties to Microsoft. In business since 1977, Skaffold believe it is poised for a promising future.
Retailers are struggling but Harvey Norman one to watch
Many people have already palmed off bricks and mortar retailers, but Harvey Norman is trading 17% above Skaffold's estimate of intrinsic value.
Good news ahead for this biotech stock
This biotech stock is focused on developing solutions to treat people with liver cancer. It also has a market capitalisation of $1.5 billion.
Resilience a factor for Macquarie Group
Skaffold's Chris Batchelor selects this month's hot stock. This company has fought hard to get back to its pre-GFC highs.
